Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Elemental chlorine or elemental chlorine releasing inorganic...
Patent
1995-04-04
1997-09-23
Pak, John
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Elemental chlorine or elemental chlorine releasing inorganic...
424677, 424678, 424679, 424680, 424681, 424682, 424686, 424717, 424722, 514 23, 514400, 514419, 514423, 514556, 514557, 514561, 514562, 514564, 514565, 514567, A61K 31195, A61K 3119, A61K 3170, A61K 3314
Patent
active
056701764
ABSTRACT:
The present invention provides a dialysis solution that contains amino acids for treating and/or preventing malnutrition in a peritoneal dialysis patient. The amino acid composition is optimized to minimize metabolic acidosis while normalizing amino acid plasma profiles.
REFERENCES:
patent: 4357343 (1982-11-01), Madsen et al.
patent: 5589197 (1996-12-01), Shockley et al.
Arfeen et al, The Nutritional/Metabolic and Hormonal Effects of 8 Weeks of Continuous Ambulatory Peritoneal Dialysis with a 1% Amino Acid Solution, Clin Nephrol, pp. 192-199 (1990).
Bruno et al, CAPD With Amino Acid Dialysis Solution: A Long Term Cross Over Study, Kidney Int., vol. 35, pp. 1189-1194 (1989).
Dommbros et al, Six-Month Overnight Intraperitoneal Amino-Acid Infusion in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients--No Effect on Nutritional Status, Peritoneal Dialysis International, vol. 10, pp. 79-84 (1990).
Jones et al, Amino Acid Solutions for CAPD; Rationale and Clinical Experience, Miner Electrolyte Metab, vol. 18, pp. 309-315 (1992).
Hanning et al, Effect of Amino Acid Containing Dialysis Solutions on Plasma Amino Acid Profiles in Children with Chronic Renal Failure, Journal of Pediatric Gastroenterology and Nutrition, vol. 6, pp. 942-947 (1987).
Kopple et al, Nutritional Effects of Intraperitoneal Amino Acids (AA) in Malnourished CAPD Patients, J Am Soc Nephrol, vol. 2, p. 362 (Abstract) (1991).
Oren et al, Effective Use of Amino Acid Dialysate Over Four Weeks in CAPD Patients, Periton Dial Bull, vol. 3, pp. 66-73 (1983).
Oreopoulos, Amino Acids as an Osmotic Agent (Instead of Glucose) in Continuous Ambulatory Peritoneal Dialysis, First International Symposium in CAPD, Paris; Excerta Medica, pp. 335-340 (1979).
Williams et al, Amino Acid Absorption Following Intraperitoneal Administration in CAPD Patients, Perit Dial Bull, pp. 124-130 (Date unknown).
Young et al, The Use of Amino Acid-Base CAPD Fluid Over 12 Weeks, Nephrol Dial Transpl, vol. 4, pp. 285-292 (1989).
Young et al, A Longitudinal Study of the Effects of Amino Acid-Based CAPD Fluid on Amino Acid Retention and Protein Losses, Nephrol Dial Transplant, pp. 1-7 (1989).
Jones Michael R.
Martis Leo
Barrett Robert M.
Baxter International Inc.
Borecki Thomas S.
Mattenson Charles R.
Pak John
LandOfFree
Amino acid solutions for treatment of peritoneal dialysis patien does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid solutions for treatment of peritoneal dialysis patien, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid solutions for treatment of peritoneal dialysis patien will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1937882